William Aronstein, Ph.D., M.D., FACP, has been promoted to vice president, Medical Affairs at CTI Clinical Trial and Consulting Services. Dr. Aronstein will oversee the activities of the Medical Affairs group, ranging from medical monitoring and protocol development, drug development strategic advice, business development, and other responsibilities.
 
Dr. Aronstein has extensive experience in early phase clinical development, including protocol development, execution, and analysis, and brings more than 30 years of clinical, academic, and industry experience. He has held numerous positions with Procter and Gamble Pharmaceuticals and was an assistant professor of Medicine at Emory University. He also held multiple positions with Johns Hopkins Hospital, including attending physician, assistant professor of Medicine, clinical director of the Division of Internal Medicine, and clinical director of Ambulatory Care in the Department of Medicine.
 
“Bill has been with CTI for over five years, and has been instrumental in helping to develop and expand the Medical Affairs team into a global wealth of knowledge,” according to Lynn Fallon, President of CTI. “His knowledge and expertise in drug development have helped many of our sponsors and staff through the regulatory processes, and he is an excellent resource for the clinical, consulting, and business development teams.”